Atropinae Sulphas, 100 Soluble Gelatin-Coated Granules
Object Details
- Sharp and Dohme
- Description
- The indications or uses for this product as provided by the manufacturer, or as found in contemporary medical literature, are:
- For use as a pain reliever, especially the pain of neuralgia and spasm, pain associated with cancer, spasm associated with tetanus or strychnine poisoning, whooping cough, epilepsy, spasmodic disorders, antidote for Calabar bean poisoning, opium poisoning, diseases of the eye, myopia, profuse sweating, diarrhoea, salivation of the insane, incontinence of urine, spermatorrhoea [involuntary discharge of semen], menorrhagia [heavy menstrual flow], pulmonary haemorrhage, ptyalism [excessive salivation], hay fever, urticaria [hives]. [The National Dispensatory, 5th Edition, 1896]
- Location
- Currently not on view
- ca 1890
- ID Number
- 1978.0883.187
- accession number
- 1978.0883
- catalog number
- 1978.0883.187
- Object Name
- pharmaceutical
- Other Terms
- Pharmaceuticals; Drugs; Non-Liquid
- Physical Description
- atropine sulphate, 1/60 gr (drug ingredient)
- glass (container material)
- cork (container material)
- paper (container material)
- Measurements
- overall: 5.5 cm x 3 cm x 1 cm; 2 3/16 in x 1 3/16 in x 3/8 in
- overall: 2 1/4 in x 1 in x 5/8 in; 5.715 cm x 2.54 cm x 1.5875 cm
- place made
- United States: Maryland, Baltimore
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Botanical Medicine
- National Museum of American History
- Subject
- Pain & Neuralgia Drugs
- Record ID
- nmah_717514
- Metadata Usage (text)
- CC0
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746a5-4f20-704b-e053-15f76fa0b4fa
Related Content
There are restrictions for re-using this image. For more information, visit the Smithsonian's Terms of Use page .
International media Interoperability Framework
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.